Shares of IDEXX Laboratories, Inc. ( NASDAQ:IDXX – Get Rating ) have earned an average rating of 'Moderate Buy' from the ten brokerages that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $520.63. Several brokerages recently issued reports on IDXX. The Goldman Sachs Group raised their target price on IDEXX Laboratories from $465.

https://www.dailypolitical.com/2023/04/16/idexx-laboratories-inc-nasdaqidxx-receives-average-recommendation-of-moderate-buy-from-brokerages.html

#dailypolitical